Best Gold Stocks To Invest In Right Now

tags:ARQL,BDX,RIGL,

The fact that Cia. de Minas Buenaventura SAA is beating rivals in the stock market at a time it’s generating the most cash in seven years says something about what investors are looking for in gold stocks.

#lazy-img-328137623:before{padding-top:66.68181818181817%;}

Roque Benavides

Photographer: Percy Ramirez/Bloomberg

Buenaventura’s U.S. shares have surged 63 percent in the past two years, the most among peers. A focus on efficiency at existing mines, while spending cautiously on projects, has helped bring down leverage metrics. Chairman Roque Benavides said analyst estimates of about $60 million free-cash flow this year, the most since 2011, “sounds reasonable.”

Speaking in an interview in Lima Tuesday, he vowed to keep trying to squeeze as much cash as possible from current operations as the company moves forward on potential new mines such as San Gabriel and Trapiche “without hurry or pause.”

Best Gold Stocks To Invest In Right Now: ArQule Inc.(ARQL)

Advisors' Opinion:

• [By Lisa Levin] Gainers Foot Locker, Inc. (NYSE: FL) rose 15.3 percent to $53.50 in pre-market trading after the company reported better-than-expected results for its first quarter. Evofem Biosciences, Inc. (NASDAQ: EVFM) rose 10.4 percent to $4.58 in pre-market trading. Evofem Biosciences reported closing of public offering of common stock and warrants. Resonant Inc. (NASDAQ: RESN) rose 7.3 percent to $4.88 in pre-market trading after declining 1.94 percent on Thursday. SolarEdge Technologies, Inc. (NASDAQ: SEDG) shares rose 5.7 percent to $59.65 in pre-market trading after falling 8.43 percent on Thursday. Yirendai Ltd. (NYSE: YRD) rose 5 percent to $30.00 in pre-market trading after reporting Q1 results. Deckers Outdoor Corp (NYSE: DECK) rose 4.9 percent to $108.75 in pre-market trading after reporteingd better-than-expected results for its fiscal fourth quarter. Blue Apron Holdings, Inc. (NYSE: APRN) rose 4.2 percent to $3.21 in pre-market trading after gaining 3.70 percent on Thursday. Recro Pharma, Inc. (NASDAQ: REPH) rose 4 percent to $5.85 in pre-market trading after dropping 54.67 percent on Thursday. ArQule, Inc. (NASDAQ: ARQL) rose 3.8 percent to $4.70 in pre-market trading after gaining 4.86 percent on Thursday. Babcock & Wilcox Enterprises, Inc. (NYSE: BW) shares rose 2.9 percent to $2.85 in pre-market trading after climbing 7.78 percent on Thursday. Bilibili Inc. (NASDAQ: BILI) shares rose 2.5 percent to $14.20 in pre-market trading after surging 11.33 percent on Thursday.

  Find out what's going on in today's market and bring any questions you have to Benzinga's PreMarket Prep.

• [By Max Byerly]

  Get a free copy of the Zacks research report on ArQule (ARQL)

  For more information about research offerings from Zacks Investment Research, visit Zacks.com

• [By Logan Wallace]

  BidaskClub upgraded shares of ArQule (NASDAQ:ARQL) from a hold rating to a buy rating in a report released on Saturday.

  A number of other research firms have also issued reports on ARQL. Roth Capital upped their price target on ArQule from $5.00 to $6.00 and gave the company a buy rating in a research report on Tuesday, April 17th. Leerink Swann upgraded ArQule from a market perform rating to an outperform rating in a research report on Thursday, April 5th. Zacks Investment Research lowered ArQule from a buy rating to a hold rating in a research report on Wednesday, April 4th. ValuEngine upgraded ArQule from a hold rating to a buy rating in a research report on Wednesday, May 2nd. Finally, B. Riley set a $4.00 price target on ArQule and gave the company a buy rating in a research report on Monday, March 26th. Seven analysts have rated the stock with a buy rating, The stock currently has an average rating of Buy and an average target price of $4.69.

• [By Stephan Byrd]

  Get a free copy of the Zacks research report on ArQule (ARQL)

  For more information about research offerings from Zacks Investment Research, visit Zacks.com

• [By Ethan Ryder]

  Get a free copy of the Zacks research report on ArQule (ARQL)

  For more information about research offerings from Zacks Investment Research, visit Zacks.com

Best Gold Stocks To Invest In Right Now: Becton, Dickinson and Company(BDX)

Advisors' Opinion:

• [By Max Byerly]

  Invivo Therapeutics (NASDAQ: NVIV) and Becton Dickinson and (NYSE:BDX) are both medical companies, but which is the superior investment? We will compare the two companies based on the strength of their profitability, dividends, risk, institutional ownership, valuation, analyst recommendations and earnings.

• [By Stephan Byrd]

  Get a free copy of the Zacks research report on Becton Dickinson and (BDX)

  For more information about research offerings from Zacks Investment Research, visit Zacks.com

• [By Joseph Griffin]

  McQueen Ball & Associates Inc. decreased its holdings in shares of Becton Dickinson and Co (NYSE:BDX) by 1.9% in the second quarter, Holdings Channel reports. The firm owned 15,033 shares of the medical instruments supplier’s stock after selling 295 shares during the quarter. Becton Dickinson and makes up 2.2% of McQueen Ball & Associates Inc.’s investment portfolio, making the stock its 8th biggest position. McQueen Ball & Associates Inc.’s holdings in Becton Dickinson and were worth $3,601,000 at the end of the most recent reporting period.

• [By Motley Fool Transcription]

  Becton Dickinson and Co. (NYSE:BDX)Q1 2019 Earnings Conference CallFeb. 5, 2019, 8:00 a.m. ET

  Contents: Prepared Remarks Questions and Answers Call Participants Prepared Remarks:

  Operator

Best Gold Stocks To Invest In Right Now: Rigel Pharmaceuticals Inc.(RIGL)

Advisors' Opinion:

• [By Dan Caplinger]

  Thursday ended in the red for most major benchmarks on Wall Street, with the Dow trading down by triple digits at times before climbing back toward the close. After having bounced back sharply in recent days, stocks seemed to lose upward momentum, and interest rate fears returned to the market. The yield on the 10-year Treasury bond once again moved above the 2.9% mark, and shorter-term Treasurys had yields reach levels they haven't seen in years. Yet even though the overall market was ready to take a break, some companies still enjoyed good news that lifted their shares. Bank of New York Mellon (NYSE:BK), Snap-on (NYSE:SNA), and Rigel Pharmaceuticals (NASDAQ:RIGL) were among the best performers on the day. Here's why they did so well.

• [By Brian Orelli]

  Shares of Rigel Pharmaceuticals (NASDAQ:RIGL) jumped 20.9% in August, according to data provided by S&P Global Market Intelligence as investors in the biotech become more comfortable with the potential of Tavalisse, Rigel's recently approved drug for chronic immune thrombocytopenia, which is characterized by low blood platelet levels.

• [By Logan Wallace]

  Get a free copy of the Zacks research report on Rigel Pharmaceuticals (RIGL)

  For more information about research offerings from Zacks Investment Research, visit Zacks.com